Analysis of interferon type I signature for differential diagnosis of diseases of the immune system ( review of literature)

Klin Lab Diagn. 2021 May 23;66(5):279-284. doi: 10.51620/0869-2084-2021-66-5-279-284.

Abstract

Type 1 interferons (IFN1) are both key molecules of antiviral defense and potent inflammatory mediators. In 2003, increased expression of a variety of interferon 1-regulated genes was observed in a blood cells of patients with systemic lupus erythematosus (SLE). This phenomenon was called the type 1 interferon signature (IFN1-signature). Since then, expression patterns indicating the presence of an IFN1-signature were consistently detected in a range of monogenic and complex autoimmune and autoinflammatory conditions. A quantitative indicator reflecting the degree of hyperactivation of the IFN1 pathway is known as interferon score. This review discusses the possible causes of upregulated expression of interferon 1-induced genes, the laboratory approaches to the interferon score analysis, as well as the practical use of this indicator for the diagnosis of various conditions.

Keywords: autoimmune disease; interferon score; interferonopathy; review; type I interferons.

Publication types

  • Review

MeSH terms

  • Diagnosis, Differential
  • Humans
  • Immune System
  • Interferon Type I* / genetics
  • Lupus Erythematosus, Systemic* / diagnosis
  • Lupus Erythematosus, Systemic* / genetics

Substances

  • Interferon Type I